BDMD (Baird Medical Investment Holdings) Gross Margin % : 87.47% (As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Baird Medical Investment Holdings Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Baird Medical Investment Holdings's Gross Profit for the six months ended in Jun. 2024 was $11.49 Mil. Baird Medical Investment Holdings's Revenue for the six months ended in Jun. 2024 was $13.14 Mil. Therefore, Baird Medical Investment Holdings's Gross Margin % for the quarter that ended in Jun. 2024 was 87.47%.

The historical rank and industry rank for Baird Medical Investment Holdings's Gross Margin % or its related term are showing as below:

BDMD' s Gross Margin % Range Over the Past 10 Years
Min: 79.9 Med: 83.61 Max: 88.41
Current: 88.41

During the past 3 years, the highest Gross Margin % of Baird Medical Investment Holdings was 88.41%. The lowest was 79.90%. And the median was 83.61%.

BDMD's Gross Margin % is ranked better than
95.16% of 806 companies
in the Medical Devices & Instruments industry
Industry Median: 52.7 vs BDMD: 88.41

Baird Medical Investment Holdings had a gross margin of 87.47% for the quarter that ended in Jun. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Baird Medical Investment Holdings was 0.00% per year.

Baird Medical Investment Holdings Gross Margin % Historical Data

The historical data trend for Baird Medical Investment Holdings's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baird Medical Investment Holdings Gross Margin % Chart

Baird Medical Investment Holdings Annual Data

Trend

Dec21

Dec22

Dec23

Gross Margin %

83.61

79.90

86.56

Baird Medical Investment Holdings Semi-Annual Data
	Dec21	Dec22	Jun23	Dec23	Jun24
Gross Margin %	-	-	82.31	89.03	87.47

Competitive Comparison of Baird Medical Investment Holdings's Gross Margin %

For the Medical Devices subindustry, Baird Medical Investment Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Baird Medical Investment Holdings's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Baird Medical Investment Holdings's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Baird Medical Investment Holdings's Gross Margin % falls into.

Baird Medical Investment Holdings Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Baird Medical Investment Holdings's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )	=	Gross Profit (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	27.2	/	31.458
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(31.458 - 4.228)	/	31.458
	=	86.56 %

Baird Medical Investment Holdings's Gross Margin for the quarter that ended in Jun. 2024 is calculated as

Gross Margin % (Q: Jun. 2024 )	=	Gross Profit (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	11.5	/	13.137
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(13.137 - 1.646)	/	13.137
	=	87.47 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Baird Medical Investment Holdings (NAS:BDMD) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Baird Medical Investment Holdings had a gross margin of 87.47% for the quarter that ended in Jun. 2024 => Durable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Baird Medical Investment Holdings Gross Margin % Related Terms

Thank you for viewing the detailed overview of Baird Medical Investment Holdings's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Baird Medical Investment Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Baird Medical Investment Holdings Ltd (NAS:BDMD) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.15 Rongtong Street, Room 202, 2nd Floor, Baide Building, Building 11, Yuexiu, Guangzhou, CHN

Website

Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.